Patents Assigned to VK RESEARCH ASSOCIATES INC.
  • Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof
    Patent number: 12023409
    Abstract: Compositions and kits for oral administration of a phosphodiesterase-4 (PDE4) inhibitor and one or more additional active agents that reduces or eliminates a side effect associated with the PDE4 inhibitor are provided. Also provided are methods for use of these compositions and kits for treating conditions treatable with a PDE4 inhibitor therapy and for increasing patient compliance with treatment with PDE4 inhibitors.
    Type: Grant
    Filed: October 19, 2022
    Date of Patent: July 2, 2024
    Assignee: VK Research Associates Inc.
    Inventors: Victor Chehebar, Siva Rama Krishna Nutalapati
  • Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof
    Patent number: 11504332
    Abstract: Compositions and kits for oral administration of a phosphodiesterase-4 (PDE4) inhibitor and one or more additional active agents that reduces or eliminates a side effect associated with the PDE4 inhibitor are provided. Also provided are methods for use of these compositions and kits for treating conditions treatable with a PDE4 inhibitor therapy and for increasing patient compliance with treatment with PDE4 inhibitors.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: November 22, 2022
    Assignee: VK RESEARCH ASSOCIATES INC.
    Inventors: Victor Chehebar, Siva Rama Krishna Nutalapati